We are live on ! Find out more
DCM

Deuterium Capital Management Portfolio holdings

AUM $92.4M
1-Year Est. Return 35%
This Fund
S&P 500
This Quarter Est. Return
+6.6%
1 Year Est. Return
+35%
3 Year Est. Return
+225.29%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$92.4M
AUM Growth
+$6.42M
Cap. Flow
+$4.14M
Cap. Flow %
4.48%
Top 10 Hldgs %
83.92%
Holding
28
New
2
Increased
3
Reduced
1
Closed
4

Top Buys

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$5.06M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$2.79M
3
UUUU icon
Energy Fuels
UUUU
+$2.76M
4
NTLA icon
Intellia Therapeutics
NTLA
+$1.4M
5
FLY
Firefly Aerospace
FLY
+$748K

Top Sells

Rank Stock Value
1
CORZ icon
Core Scientific
CORZ
+$4.49M
2
TGT icon
Target
TGT
+$2.42M
3
NKTR icon
Nektar Therapeutics
NKTR
+$1.3M
4
SDRL icon
Seadrill
SDRL
+$228K
5
IMPP icon
Imperial Petroleum
IMPP
+$179K

Sector Composition

Rank Sector Weight
1 Communication Services 23.9%
2 Technology 20.25%
3 Healthcare 14.93%
4 Consumer Discretionary 13.93%
5 Materials 10.66%

No holdings matched the selected filter criteria.

1 2

Similar funds

AW
Aspirean Wealth Mill Valley, California $92.1M AUM
ACMC
Anchor Capital Management Company Raleigh, North Carolina $92.7M AUM 19.36% 1-Year Est. Return
KA
Kore Advisors Boynton Beach, Florida $92.9M AUM 730.09% 1-Year Est. Return
MA
Marquette Associates Chicago, Illinois $91.9M AUM 13.47% 1-Year Est. Return
SSCM
Seven Six Capital Management New York $93M AUM 12.51% 1-Year Est. Return
ITG
Index Technologies Group New York $91.8M AUM
KAM
Kazazian Asset Management Fort Lauderdale, Florida $91.5M AUM 35.36% 1-Year Est. Return
MRP
Measured Risk Portfolios San Diego, California $91.4M AUM 0.88% 1-Year Est. Return

Deuterium Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, Deuterium Capital Management held 28 positions worth $92.4M, up 7.5% from $86M the previous quarter. Its ten largest holdings account for 84% of the portfolio.

Deuterium Capital Management deployed $4.14M of net new capital in Q2 2026, opening 2 new positions and adding to 3 existing holdings. Its largest new stake was Intellia Therapeutics: 100,000 shares worth $1.69M.

By sector, the portfolio is most concentrated in Communication Services at 24% of assets, up from 18% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Imperial Petroleum, an estimated $179K trimmed.

  • Deuterium Capital Management's largest Q2 2026 buy was Intellia Therapeutics: 100,000 shares worth $1.69M.
  • Deuterium Capital Management added most to Intuitive Surgical in Q2 2026, an estimated $5.06M increase.
  • Deuterium Capital Management's biggest Q2 2026 reduction was Imperial Petroleum, cutting an estimated $179K.
  • Deuterium Capital Management fully exited Core Scientific in Q2 2026, selling an estimated $4.49M.
  • Deuterium Capital Management's ten largest holdings make up 84% of its $92.4M portfolio in Q2 2026.
  • Deuterium Capital Management opened 2 new positions and closed 4 in Q2 2026.
  • Deuterium Capital Management's portfolio value rose 7.5% quarter-over-quarter to $92.4M.

Based on Deuterium Capital Management's 13F filing for Q2 2026, filed 5 Aug 2026.